欧洲白血病网络：成就与展望。
The European LeukemiaNet: achievements and perspectives.
机构信息
Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.
出版信息
Haematologica. 2011 Jan;96(1):156-62. doi: 10.3324/haematol.2010.032979. Epub 2010 Nov 3.
Abstract
The only way to cure leukemia is by cooperative research. To optimize research, the European LeukemiaNet integrates 105 national leukemia trial groups and networks, 105 interdisciplinary partner groups and about 1,000 leukemia specialists from 175 institutions. They care for tens of thousands of leukemia patients in 33 countries across Europe. Their ultimate goal is to cure leukemia. Since its inception in 2002, the European LeukemiaNet has steadily expanded and has unified leukemia research across Europe. The European LeukemiaNet grew from two major roots: 1) the German Competence Network on Acute and Chronic Leukemias; and 2) the collaboration of European Investigators on Chronic Myeloid Leukemia. The European LeukemiaNet has improved leukemia research and management across Europe. Its concept has led to funding by the European Commission as a network of excellence. Other sources (European Science Foundation; European LeukemiaNet-Foundation) will take over when the support of the European Commission ends.
摘要
治愈白血病的唯一方法是合作研究。为了优化研究，欧洲白血病网整合了 105 个国家的白血病试验组和网络、105 个跨学科合作组以及来自 175 个机构的约 1000 名白血病专家。他们在欧洲 33 个国家照顾着成千上万的白血病患者。他们的最终目标是治愈白血病。自 2002 年成立以来，欧洲白血病网稳步发展，统一了全欧洲的白血病研究。欧洲白血病网起源于两个主要分支：1）德国急性和慢性白血病能力网络；2）欧洲慢性髓性白血病研究者的合作。欧洲白血病网改善了全欧洲的白血病研究和管理。其理念已促使欧洲委员会将其作为卓越网络提供资金。当欧洲委员会的支持结束时，其他来源（欧洲科学基金会；欧洲白血病网基金会）将接管。
相似文献
1
The European LeukemiaNet: achievements and perspectives.欧洲白血病网络：成就与展望。
Haematologica. 2011 Jan;96(1):156-62. doi: 10.3324/haematol.2010.032979. Epub 2010 Nov 3.
2
[Clinical research within the German competence net "acute and chronic leukemias"].[德国“急性和慢性白血病”能力网络内的临床研究]
Med Klin (Munich). 2006 May 15;101(5):414-20. doi: 10.1007/s00063-006-1056-2.
3
[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Apr;59(4):444-53. doi: 10.1007/s00103-016-2315-x.
4
Advancing a field by building consortia: The example of the European LeukemiaNet.通过建立联盟推动一个领域的发展：以欧洲白血病网为例。
Cancer. 2018 Mar 15;124(6):1100-1104. doi: 10.1002/cncr.31199. Epub 2018 Feb 16.
5
[Clinical research in the "acute and chronic leukemias"competence network ].["急性和慢性白血病”能力网络中的临床研究]
Internist (Berl). 2004 Apr;45(4):384-92. doi: 10.1007/s00108-004-1151-5.
6
[Clinical research at the European LeukemiaNet].[欧洲白血病网的临床研究]
Dtsch Med Wochenschr. 2006 Oct 27;131(43):2423-6. doi: 10.1055/s-2006-955027.
7
Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project.欧洲患癌青少年及青年：从国家项目到欧洲综合协调项目
Eur J Cancer Care (Engl). 2016 May;25(3):419-27. doi: 10.1111/ecc.12365. Epub 2015 Aug 4.
8
Consensus document on European brain research.欧洲脑研究共识文件。
J Neurol Neurosurg Psychiatry. 2006 Aug;77 Suppl 1(Suppl 1):i1-49.
9
[The German Cancer Society].[德国癌症协会]
Z Gastroenterol. 2014 Jan;52(1):18. doi: 10.1055/s-0033-1362154.
10
Europe, China and the world: the EAPCI international membership.欧洲、中国与世界：欧洲经皮心血管介入学会国际会员
EuroIntervention. 2012 Nov 22;8(7):779-81. doi: 10.4244/EIJV8I7A120.
引用本文的文献
1
Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML.急性髓系白血病中遗传、表观遗传和细胞遗传学异常的差异分析
Int J Genomics. 2017;2017:2913648. doi: 10.1155/2017/2913648. Epub 2017 Jun 20.
2
The European Hematology Association Roadmap for European Hematology Research: a consensus document.欧洲血液学协会欧洲血液学研究路线图：一份共识文件。
Haematologica. 2016 Feb;101(2):115-208. doi: 10.3324/haematol.2015.136739. Epub 2016 Jan 27.
3
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.慢性髓性白血病治疗后深度分子反应评分的实验室建议。
Leukemia. 2015 May;29(5):999-1003. doi: 10.1038/leu.2015.29. Epub 2015 Feb 5.
4
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality.一项旨在确定急性白血病成年患者造血干细胞移植可行性的前瞻性注册研究：规划、预期与现实。
Bone Marrow Transplant. 2014 Mar;49(3):376-81. doi: 10.1038/bmt.2013.178. Epub 2013 Nov 18.
5
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.成人原发性骨髓增生异常综合征的诊断和治疗：欧洲白血病网络的建议。
Blood. 2013 Oct 24;122(17):2943-64. doi: 10.1182/blood-2013-03-492884. Epub 2013 Aug 26.
6
Value of multifaced approach diagnosis and classification of acute leukemias.多方面方法对急性白血病进行诊断和分类的价值。
Maedica (Bucur). 2012 Sep;7(3):254-60.
7
New opportunities and new problems for acute myeloid leukemia treatment.急性髓系白血病治疗的新机遇与新问题
Haematologica. 2012 Jun;97(6):796. doi: 10.3324/haematol.2012.070243.
本文引用的文献
1
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.费城阴性经典骨髓增殖性肿瘤：来自欧洲白血病网络的关键概念和管理建议。
J Clin Oncol. 2011 Feb 20;29(6):761-70. doi: 10.1200/JCO.2010.31.8436. Epub 2011 Jan 4.
2
Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria.羟基脲治疗原发性血小板增多症：根据欧洲白血病网络标准的反应率及临床相关性。
Blood. 2010 Aug 19;116(7):1051-5. doi: 10.1182/blood-2010-03-272179. Epub 2010 May 17.
3
JAK2V617F mutation persists in blasts and mature cells of transformed JAK2V617F-positive-myeloproliferative neoplasia: a European Leukemia Net (ENL) study.JAK2V617F突变在转化型JAK2V617F阳性骨髓增殖性肿瘤的原始细胞和成熟细胞中持续存在：一项欧洲白血病网（ELN）研究。
Am J Hematol. 2010 May;85(5):383-6. doi: 10.1002/ajh.21687.
4
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.基于微阵列的基因表达谱分析在白血病诊断和亚分类中的临床应用：来自国际白血病微阵列创新研究组的报告。
J Clin Oncol. 2010 May 20;28(15):2529-37. doi: 10.1200/JCO.2009.23.4732. Epub 2010 Apr 20.
5
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.异基因造血干细胞移植（allo SCT）在伊马替尼时代治疗慢性髓性白血病：在德国 CML 研究 IV 随机亚组内评估其影响。
Blood. 2010 Mar 11;115(10):1880-5. doi: 10.1182/blood-2009-08-237115. Epub 2009 Nov 18.
6
A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process.真性红细胞增多症和原发性骨髓纤维化中对羟基脲临床耐药和不耐受的统一定义：欧洲白血病网（ELN）共识过程的结果
Br J Haematol. 2010 Mar;148(6):961-3. doi: 10.1111/j.1365-2141.2009.08019.x. Epub 2009 Nov 23.
7
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.慢性髓性白血病：欧洲白血病网络概念与管理建议的更新
J Clin Oncol. 2009 Dec 10;27(35):6041-51. doi: 10.1200/JCO.2009.25.0779. Epub 2009 Nov 2.
8
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.成人急性髓系白血病的诊断和治疗：代表欧洲白血病网的国际专家小组的建议。
Blood. 2010 Jan 21;115(3):453-74. doi: 10.1182/blood-2009-07-235358. Epub 2009 Oct 30.
9
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.通过标准化WT1检测进行实时定量聚合酶链反应检测急性髓系白血病微小残留病以加强风险分层：一项欧洲白血病网研究
J Clin Oncol. 2009 Nov 1;27(31):5195-201. doi: 10.1200/JCO.2009.22.4865. Epub 2009 Sep 14.
10
Harmonization of molecular monitoring of CML therapy in Europe.欧洲慢性粒细胞白血病治疗分子监测的协调统一
Leukemia. 2009 Nov;23(11):1957-63. doi: 10.1038/leu.2009.168. Epub 2009 Aug 27.
Zotero 插件